Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction

Published:2022-05 Issue:5 Volume:10 Page:336-346
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Cikes Maja,Planinc Ivo,Claggett Brian,Cunningham Jonathan,Milicic Davor,Sweitzer Nancy,Senni Michele,Gori Mauro,Linssen Gerard,Shah Sanjiv J.,Packer Milton,Pfeffer Marc,Zile Michael R.,Anand Inder,Chiang Lu-May,Lam Carolyn S.P.,Redfield Margaret,Desai Akshay S.,McMurray John J.V.,Solomon Scott D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart Failure—Assessment of Reduction in Mortality and Morbidity (CHARM) program;Olsson;J Am Coll Cardiol,2006

2. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study;Zakeri;Circulation,2013

3. Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins;Kotecha;J Am Coll Cardiol,2016

4. Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction;Sartipy;J Am Coll Cardiol HF,2017

5. History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction;Oluleye;Circ Heart Fail,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review and meta‐analysis to predict mortality in heart failure with preserved ejection fraction: Development and validation of the HF‐DANAS score;ESC Heart Failure;2024-08-08

2. Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Angiotensin Receptor‐Neprilysin Inhibitors in Patients With Atrial Fibrillation and Heart Failure From 2021 to 2022: An Analysis of Real‐World Data;Journal of the American Heart Association;2024-03-19

3. Atrial Fibrillation Management With Antiarrhythmic Drug Therapy;Journal of the American College of Cardiology;2024-03

4. Association of Antiarrhythmic Drug Therapy With Syncope and Pacemaker Implantation in Patients With Atrial Fibrillation;Journal of the American College of Cardiology;2024-03

5. Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure;Journal of the American College of Cardiology;2024-03